Page last updated: 2024-11-05

triazolam and Agitation, Psychomotor

triazolam has been researched along with Agitation, Psychomotor in 2 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Research Excerpts

ExcerptRelevanceReference
"Side effects involving agitation, e."1.27Agitation observed during treatment with newer hypnotic drugs. ( Regestein, QR; Reich, P, 1985)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cotroneo, A1
Gareri, P1
Nicoletti, N1
Lacava, R1
Grassone, D1
Maina, E1
De Sarro, G1
Cabodi, S1
Regestein, QR1
Reich, P1

Other Studies

2 other studies available for triazolam and Agitation, Psychomotor

ArticleYear
Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people.
    Archives of gerontology and geriatrics, 2007, Volume: 44 Suppl 1

    Topics: Aged; Cognition Disorders; Dementia; Depression; Drug Administration Schedule; Female; Health Status

2007
Agitation observed during treatment with newer hypnotic drugs.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:7

    Topics: Adult; Aged; Akathisia, Drug-Induced; Anger; Anti-Anxiety Agents; Female; Half-Life; Hostility; Huma

1985